No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹76.15Prev. Close
₹76.16Turnover(Lac.)
₹1.53Day's High
₹76.15Day's Low
₹7552 Week's High
₹90.8552 Week's Low
₹66Book Value
₹38.68Face Value
₹10Mkt Cap (₹ Cr.)
22.72P/E
32.27EPS
2.36Divi. Yield
027 Aug 2026
12:00 AM
AGM
Announcement Date: 27 Aug, 2026
27 Aug 2026
12:00 AM
BookCloser
18 Sep 2026
12:00 AM
Board Meeting
Agenda : Audited Result
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 2.99 | 2.99 | 2.99 | 2.99 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 8.58 | 7.8 | 6.93 | 6.18 |
Net Worth | 11.57 | 10.79 | 9.92 | 9.17 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 13.94 | 14.83 | 6.84 | 6.43 |
yoy growth (%) | -5.95 | 116.75 | 6.26 | -9.32 |
Raw materials | -10.28 | -11.44 | -4.73 | -3.97 |
As % of sales | 73.74 | 77.16 | 69.16 | 61.68 |
Employee costs | -1.09 | -1.09 | -0.79 | -0.69 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 1.05 | 0.71 | 0.32 | 0.25 |
Depreciation | -0.14 | -0.17 | -0.13 | -0.13 |
Tax paid | -0.22 | -0.16 | -0.07 | -0.07 |
Working capital | 2.9 | -1.04 | -0.26 | -1.4 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -5.95 | 116.75 | 6.26 | -9.32 |
Op profit growth | 20.26 | 92.91 | 9.73 | 31.17 |
EBIT growth | 45.07 | 71.67 | 44.5 | 21.42 |
Net profit growth | 51.63 | 120.78 | 35.8 | 33.01 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,752.5 | 132.06 | 4,20,483.45 | 1,115.14 | 0.91 | 5,641.31 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 9,389 | 83.2 | 2,49,248.45 | 891 | 0.32 | 2,974 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,675 | 86.7 | 1,77,821.97 | 492 | 0.72 | 4,073 | 222.76 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,115.2 | 30.52 | 1,11,241.63 | 339.6 | 0.09 | 2,723.5 | 237.3 |
Laurus Labs Ltd LAURUSLABS | 2,000 | 123.84 | 1,08,062.44 | 289.96 | 0.1 | 1,757.16 | 97.2 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Jagdish Agrawal
Non Executive Director
Abha Agrawal
Independent Non Exe. Director
Arvind Sapkal
Independent Non Exe. Director
Dhwani Jaypalsinh Solanki
Company Sec. & Compli. Officer
Srushti Pandya
Survey No 179/1 Taluka Sanand,
Village Vasna-Iyava,
Gujarat - 382170
Tel: -
Website: http://www.ishitadrugs.com
Email: ishitadrugs@vsnl.net
E-2/3 Saki Vihar Rd,
Ansa Indl Estate, Saki Naka Andheri-E,
Mumbai - 400 072
Tel: 91-22-40430200
Website: www.bigshareonline.com
Email: info@bigshareonline.com
Summary
Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemic...
Read More
Reports by Ishita Drugs & Industries Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
